EN2 overexpression was confirmed in an independent cohort of fresh PCa biopsies from high-risk/locally-advanced PCa patients (n = 23) vs. fresh normal prostate tissues (n = 7) (Figure 1b, left-panel). The gene discussed is EN2; the disease is posterior cortical atrophy.